Press releases

Varian Announces CEO Succession Plan

Varian (NYSE: VAR) today announced that Chief Executive Officer Dow Wilson, after more than 16 years with the Company, will retire upon the successful completion of the proposed combination of...

CTSI Oncology Solutions, a Varian Company, to Provide Technology-Enabled Services for Radiation Oncology at CHRISTUS Health

CTSI Oncology Solutions, a Varian (NYSE: VAR) company that provides oncology services for healthcare providers worldwide, has entered into a long-term, multi-year agreement with CHRISTUS Health, a...

Varian Becomes First Medical Technology Company Joining the Cancer Drug Development Forum

Varian (NYSE: VAR) announced it has joined the Cancer Drug Development Forum (CDDF) as an industry partner. This makes Varian the first medical technology company to join CDDF, the leading...

News Items

Varian and Yonsei Cancer Center, Yonsei University Health System Sign MOU to Further Innovation to Treat Cancer Patients

Varian announced that it has entered into a three-year agreement with Yonsei Cancer Center, Yonsei University Health System to collaborate on research and development projects in the field of radiation therapy and oncology. Cancer is the leading…

Varian Partners with Sony Foundation Australia in the You Can Stay Program

Varian announced it has entered a partnership with Sony Foundation Australia to support its You Can Stay Program. The You Can Stay program provides free accommodations for cancer patients aged between 15 to 25 and their families in Australia who…

Varian Installs Cyclotron for ProBeam Proton Therapy System at Guangzhou Concord Cancer Center

Varian announced the installation of the cyclotron for its ProBeam® proton therapy system at the Guangzhou Concord Cancer Center. As a core piece of the system, the accelerator weighs 90 tons. Its installation marks a key milestone for the new…

Postagens do blog

The Impact of COVID-19 on Lung Cancer Treatment in Europe


Prior to the pandemic, lung cancer was the leading cause of cancer deaths worldwide. Without addressing the impact of COVID-19 on lung cancer services and ensuring long-term resilience, report shows how that trend looks set to increase.

Ler mais

Putting Patient Safety Front and Center with IDENTIFY


As part of its ongoing commitment to Intelligent Cancer Care, Varian combines innovation with advances in patient identification, safety, and motion tracking to offer a comprehensive patient guidance system. The Varian IDENTIFY™ system is incorporated wit...

Ler mais

Brachytherapy Applicators for Gynecological Treatment: No Longer One-Size-Fits-All


In the US alone, more than 110,000 new cases of gynecological cancer are diagnosed each year, with more than 32,000 deaths, according to the American Cancer Society.

Ler mais

Image Gallery

Brachytherapy Treatment Planning Systems
Clinac® iX medical linear accelerator, rotating
Ethos™ therapy
Ethos™ therapy